These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19519443)

  • 41. [Intestinal microbiota: from antibiotic-associated diarrhea to inflammatory bowel diseases].
    Quévrain E; Seksik P
    Presse Med; 2013 Jan; 42(1):45-51. PubMed ID: 23260759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human gut microbiome and body metabolism: implications for obesity and diabetes.
    Devaraj S; Hemarajata P; Versalovic J
    Clin Chem; 2013 Apr; 59(4):617-28. PubMed ID: 23401286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbes inside--from diversity to function: the case of Akkermansia.
    Belzer C; de Vos WM
    ISME J; 2012 Aug; 6(8):1449-58. PubMed ID: 22437156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interplay between intestinal bacteria and host metabolism in health and disease: lessons from Drosophila melanogaster.
    Wong AC; Vanhove AS; Watnick PI
    Dis Model Mech; 2016 Mar; 9(3):271-81. PubMed ID: 26935105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbiome and cancer.
    Ohtani N
    Semin Immunopathol; 2015 Jan; 37(1):65-72. PubMed ID: 25404117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Programming of host metabolism by the gut microbiota.
    Bäckhed F
    Ann Nutr Metab; 2011; 58 Suppl 2():44-52. PubMed ID: 21846980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Advances in host-microbe metabolic axis].
    Pi Y; Gao K; Zhu W
    Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):161-9. PubMed ID: 29750478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiota, host gene expression, and aging.
    Patrignani P; Tacconelli S; Bruno A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S28-31. PubMed ID: 25291121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of microbiota in postnatal maturation of intestinal T-cell responses.
    Gaboriau-Routhiau V; Lécuyer E; Cerf-Bensussan N
    Curr Opin Gastroenterol; 2011 Oct; 27(6):502-8. PubMed ID: 21946030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obesity and the gut microbiota.
    Flint HJ
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S128-32. PubMed ID: 21992951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis.
    Nagai M; Obata Y; Takahashi D; Hase K
    Int Immunopharmacol; 2016 Aug; 37():79-86. PubMed ID: 27133028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nutrition, microbiomes, and intestinal inflammation.
    Devkota S; Chang EB
    Curr Opin Gastroenterol; 2013 Nov; 29(6):603-7. PubMed ID: 24100722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease.
    Wieland A; Frank DN; Harnke B; Bambha K
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1051-63. PubMed ID: 26304302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
    Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.